The expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development

Pharmacological Research

Volumn 110, Issue , 2016, Pages 52-64

  Hullmann, Jonathan ^b   Traynham, Christopher J ^a   Coleman, Ryan C ^a   Koch, Walter J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

G protein coupled receptor; G protein coupled receptor kinase; Heart failure; Hypertrophy; Myocardium

Indexed keywords

BETA ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; G PROTEIN COUPLED RECEPTOR KINASE 2; G PROTEIN COUPLED RECEPTOR KINASE 3; G PROTEIN COUPLED RECEPTOR KINASE 4; G PROTEIN COUPLED RECEPTOR KINASE 5; MICRORNA; ADRBK1 PROTEIN, HUMAN; ENZYME INHIBITOR; GRK5 PROTEIN, HUMAN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; DESENSITIZATION; ENZYME INHIBITION; GENE THERAPY; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE INJURY; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIOVASCULAR SYSTEM; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HEART FAILURE; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; CARDIOVASCULAR SYSTEM; ENZYME INHIBITORS; G-PROTEIN-COUPLED RECEPTOR KINASE 2; G-PROTEIN-COUPLED RECEPTOR KINASE 5; GENETIC THERAPY; HEART FAILURE; HUMANS; MICRORNAS; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION;

EID: 84969756546     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2016.05.008     Document Type: Review

References (131)

1. R.J. Lefkowitz Seven transmembrane receptors: something old, something new Acta Physiol. (Oxf.) 190 1 2007 9 19
2. V. Katritch, V. Cherezov, and R.C. Stevens Structure-function of the G protein-coupled receptor superfamily Annu. Rev. Pharmacol. Toxicol. 53 2013 531 556 10.1146/annurev-pharmtox-032112-135923
3. J.P. Overington, B. Al-Lazikani, and A.L. Hopkins How many drug targets are there? Nat. Rev. Drug Discov. 5 12 2006 993 996
4. K.L. Pierce, and R.J. Lefkowitz Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors Nat. Rev. Neurosci. 2 10 2001 727 733
5. C.A. Moore, S.K. Milano, and J.L. Benovic Regulation of receptor trafficking by GRKs and arrestins Annu. Rev. Physiol. 69 2007 451 482
6. J.A. Pitcher, N.J. Freedman, and R.J. Lefkowitz G protein-coupled receptor kinases Annu. Rev. Biochem. 67 1998 653 692
7. R.T. Premont, and R.R. Gainetdinov Physiological roles of G protein-coupled receptor kinases and arrestins Annu. Rev. Physiol. 69 2007 511 534
8. M.T. Drake, S.K. Shenoy, and R.J. Lefkowitz Trafficking of G protein-coupled receptors Circ. Res. 99 6 2006 570 582
9. R.R. Gainetdinov, L.M. Bohn, J.K. Walker, S.A. Laporte, A.D. Macrae, M.G. Caron, R.J. Lefkowitz, and R.T. Premont Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice Neuron 24 4 1999 1029 1036
10. K.T. Homan, and J.J. Tesmer Structural insights into G protein-coupled receptor kinase function Curr. Opin. Cell Biol. 27 2014 25 31 10.1016/j.ceb.2013.10.009
11. P.W. Day, P.B. Wedegaertner, and J.L. Benovic Analysis of G-protein-coupled receptor kinase RGS homology domains Methods Enzymol. 390 2004 295 310
12. S.M. Schumacher, E. Gao, M. Cohen, M. Lieu, J. Kurt Chuprun, and W.J. Koch A peptide of the RGS domain of GRK2 binds and inhibits Galphaq to suppress pathological cardiac hypertrophy and dysfunction Sci. Signal. 9 420 2016 ra30 10.1126/scisignal.aae0549
13. Z.M. Huang, J.I. Gold, and W.J. Koch G protein-coupled receptor kinases in normal and failing myocardium Front. Biosci. 16 2011 3047 3060
14. K. Haga, K. Kameyama, and T. Haga Synergistic activation of a G protein-coupled receptor kinase by G protein beta gamma subunits and mastoparan or related peptides J. Biol. Chem. 269 17 1994 12594 12599
15. J.A. Pitcher, Z.L. Fredericks, W.C. Stone, R.T. Premont, R.H. Stoffel, W.J. Koch, and R.J. Lefkowitz Phosphatidylinositol 4,5-bisphosphate (PIP2)-enhanced G protein-coupled receptor kinase (GRK) activity. Location, structure, and regulation of the PIP2 binding site distinguishes the GRK subfamilies J. Biol. Chem. 271 40 1996 24907 24913
16. E.V. Gurevich, J.J. Tesmer, A. Mushegian, and V.V. Gurevich G protein-coupled receptor kinases: more than just kinases and not only for GPCRs Pharmacol. Ther. 133 1 2012 40 69 10.1016/j.pharmthera.2011.08.001
17. M.M. Thiyagarajan, R.P. Stracquatanio, A.N. Pronin, D.S. Evanko, J.L. Benovic, and P.B. Wedegaertner A predicted amphipathic helix mediates plasma membrane localization of GRK5 J. Biol. Chem. 279 17 2004 17989 17995
18. G.W. Dorn 2nd GRK mythology: G-protein receptor kinases in cardiovascular disease J. Mol. Med. (Berl.) 87 5 2009 455 463 10.1007/s00109-009-0450-7
19. J.L. Benovic, J.J. Onorato, J.L. Arriza, W.C. Stone, M. Lohse, N.A. Jenkins, D.J. Gilbert, N.G. Copeland, M.G. Caron, and R.J. Lefkowitz Cloning, expression, and chromosomal localization of beta-adrenergic receptor kinase 2. A new member of the receptor kinase family J. Biol. Chem. 266 23 1991 14939 14946
20. P. Kunapuli, and J.L. Benovic Cloning and expression of GRK5: a member of the G protein-coupled receptor kinase family Proc. Natl. Acad. Sci. U. S. A. 90 12 1993 5588 5592
21. R.T. Premont, W.J. Koch, J. Inglese, and R.J. Lefkowitz Identification, purification, and characterization of GRK5, a member of the family of G protein-coupled receptor kinases J. Biol. Chem. 269 9 1994 6832 6841
22. J.L. Benovic, and J. Gomez Molecular cloning and expression of GRK6. A new member of the G protein-coupled receptor kinase family J. Biol. Chem. 268 26 1993 19521 19527
23. M. Jaber, W.J. Koch, H. Rockman, B. Smith, R.A. Bond, K.K. Sulik, J. Ross Jr., R.J. Lefkowitz, M.G. Caron, and B. Giros Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function Proc. Natl. Acad. Sci. U. S. A. 93 23 1996 12974 12979
24. S.J. Matkovich, A. Diwan, J.L. Klanke, D.J. Hammer, Y. Marreez, A.M. Odley, E.W. Brunskill, W.J. Koch, R.J. Schwartz, and G.W. Dorn 2nd Cardiac-specific ablation of G-protein receptor kinase 2 redefines its roles in heart development and beta-adrenergic signaling Circ. Res. 99 9 2006 996 1003
25. M.D. Burkhalter, G.B. Fralish, R.T. Premont, M.G. Caron, and M. Philipp Grk5l controls heart development by limiting mTOR signaling during symmetry breaking Cell Rep. 4 4 2013 625 632 10.1016/j.celrep.2013.07.036
26. E. Braunwald, and M.R. Bristow Congestive heart failure: fifty years of progress Circulation 102 20 Suppl. 4 2000 IV14 IV23
27. A. Lymperopoulos, G. Rengo, and W.J. Koch Adrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation Trends Mol. Med. 13 12 2007 503 511
28. P.Y. Sato, J.K. Chuprun, M. Schwartz, and W.J. Koch The evolving impact of g protein-coupled receptor kinases in cardiac health and disease Physiol. Rev. 95 2 2015 377 404 10.1152/physrev.00015.2014
29. M. Packer The development of positive inotropic agents for chronic heart failure: how have we gone astray? J. Am. Coll. Cardiol. 22 4 Suppl. A 1993 119A 126A
30. A.M. Feldman, and C. McTiernan New insight into the role of enhanced adrenergic receptor-effector coupling in the heart Circulation 100 6 1999 579 582
31. S.M. Schumacher, E. Gao, W. Zhu, X. Chen, J.K. Chuprun, A.M. Feldman, G.T. JJ, and W.J. Koch Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction Sci. Transl. Med. 7 277 2015 277ra31 10.1126/scitranslmed.aaa0154
32. P.W. Raake, L.E. Vinge, E. Gao, M. Boucher, G. Rengo, X. Chen, B.R. DeGeorge Jr., S. Matkovich, S.R. Houser, P. Most, A.D. Eckhart, G.W. Dorn 2nd, and W.J. Koch G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure Circ. Res. 103 4 2008 413 422 10.1161/CIRCRESAHA.107.168336
33. G. Rengo, A. Lymperopoulos, C. Zincarelli, M. Donniacuo, S. Soltys, J.E. Rabinowitz, and W.J. Koch Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure Circulation 119 1 2009 89 98 10.1161/CIRCULATIONAHA.108.803999
34. W.J. Koch, H.A. Rockman, P. Samama, R.A. Hamilton, R.A. Bond, C.A. Milano, and R.J. Lefkowitz Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor Science 268 5215 1995 1350 1353
35. M.R. Bristow, R.E. Hershberger, J.D. Port, W. Minobe, and R. Rasmussen Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium Mol. Pharmacol. 35 3 1989 295 303
36. C. Dessy, and J.L. Balligand Beta3-adrenergic receptors in cardiac and vascular tissues emerging concepts and therapeutic perspectives Adv. Pharmacol. 59 2010 135 163 10.1016/S1054-3589(10)59005-7
37. W. Wang, H. Zhang, H. Gao, H. Kubo, R.M. Berretta, X. Chen, and S.R. Houser {beta}1-Adrenergic receptor activation induces mouse cardiac myocyte death through both L-type calcium channel-dependent and -independent pathways Am. J. Physiol. Heart Circ. Physiol. 299 2 2010 H322 H331 10.1152/ajpheart.00392.2010
38. A.J. Patterson, W. Zhu, A. Chow, R. Agrawal, J. Kosek, R.P. Xiao, and B. Kobilka Protecting the myocardium: a role for the beta2 adrenergic receptor in the heart Crit. Care Med. 32 4 2004 1041 1048
39. R.P. Xiao, W. Zhu, M. Zheng, C. Cao, Y. Zhang, E.G. Lakatta, and Q. Han Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart Trends Pharmacol. Sci. 27 6 2006 330 337
40. H.H. Rasmussen, G.A. Figtree, H. Krum, and H. Bundgaard The use of beta3-adrenergic receptor agonists in the treatment of heart failure Curr. Opin. Investig. Drugs 10 9 2009 955 962
41. M.R. Bristow, R. Ginsburg, W. Minobe, R.S. Cubicciotti, W.S. Sageman, K. Lurie, M.E. Billingham, D.C. Harrison, and E.B. Stinson Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts N. Engl. J. Med. 307 4 1982 205 211
42. M.R. Bristow, R. Ginsburg, V. Umans, M. Fowler, W. Minobe, R. Rasmussen, P. Zera, R. Menlove, P. Shah, S. Jamieson, and et al. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure Circ. Res. 59 3 1986 297 309
43. A. Lymperopoulos, G. Rengo, and W.J. Koch Adrenergic nervous system in heart failure: pathophysiology and therapy Circ. Res. 113 6 2013 739 753 10.1161/CIRCRESAHA.113.300308
44. C. Belge, J. Hammond, E. Dubois-Deruy, B. Manoury, J. Hamelet, C. Beauloye, A. Markl, A.C. Pouleur, L. Bertrand, H. Esfahani, K. Jnaoui, K.R. Gotz, V.O. Nikolaev, A. Vanderper, P. Herijgers, I. Lobysheva, G. Iaccarino, D. Hilfiker-Kleiner, G. Tavernier, D. Langin, C. Dessy, and J.L. Balligand Enhanced expression of beta3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase Circulation 129 4 2014 451 462 10.1161/CIRCULATIONAHA.113.004940
45. M. Ungerer, M. Bohm, J.S. Elce, E. Erdmann, and M.J. Lohse Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart Circulation 87 2 1993 454 463
46. K. Leineweber, S. Klapproth, A. Beilfuss, R.E. Silber, G. Heusch, T. Philipp, and O.E. Brodde Unchanged G-protein-coupled receptor kinase activity in the aging human heart J. Am. Coll. Cardiol. 42 8 2003 1487 1492
47. D.G. Tilley, and H.A. Rockman Role of beta-adrenergic receptor signaling and desensitization in heart failure: new concepts and prospects for treatment Expert Rev. Cardiovasc. Ther. 4 3 2006 417 432
48. D.C. White, J.A. Hata, A.S. Shah, D.D. Glower, R.J. Lefkowitz, and W.J. Koch Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction Proc. Natl. Acad. Sci. U. S. A. 97 10 2000 5428 5433
49. G. Iaccarino, E.D. Tomhave, R.J. Lefkowitz, and W.J. Koch Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade Circulation 98 17 1998 1783 1789
50. G. Iaccarino, E. Barbato, E. Cipolletta, V. De Amicis, K.B. Margulies, D. Leosco, B. Trimarco, and W.J. Koch Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure Eur. Heart J. 26 17 2005 1752 1758
51. J.A. Hata, M.L. Williams, J.N. Schroder, B. Lima, J.R. Keys, B.C. Blaxall, J.A. Petrofski, A. Jakoi, C.A. Milano, and W.J. Koch Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading J. Card. Fail. 12 5 2006 360 368
52. R.E. Bonita, P.W. Raake, N.J. Otis, J.K. Chuprun, T. Spivack, A. Dasgupta, D.J. Whellan, P.J. Mather, and W.J. Koch Dynamic changes in lymphocyte GRK2 levels in cardiac transplant patients: a biomarker for left ventricular function Clin. Transl. Sci. 3 1 2010 14 18 10.1111/j.1752-8062.2010.00176.x
53. G. Rengo, G. Pagano, P.P. Filardi, G.D. Femminella, V. Parisi, A. Cannavo, D. Liccardo, K. Komici, G. Gambino, M.L. D'Amico, C. de Lucia, S. Paolillo, B. Trimarco, D.F. Vitale, N. Ferrara, W.J. Koch, and D. Leosco Prognostic value of lymphocyte G protein-Coupled receptor kinase-2 protein levels in patients with heart failure Circ. Res. 118 7 2016 1116 1124 10.1161/CIRCRESAHA.115.308207
54. S.A. Akhter, A.D. Eckhart, H.A. Rockman, K. Shotwell, R.J. Lefkowitz, and W.J. Koch In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function Circulation 100 6 1999 648 653
55. H.A. Rockman, K.R. Chien, D.J. Choi, G. Iaccarino, J.J. Hunter, J. Ross Jr., R.J. Lefkowitz, and W.J. Koch Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice Proc. Natl. Acad. Sci. U. S. A. 95 12 1998 7000 7005
56. V.B. Harding, L.R. Jones, R.J. Lefkowitz, W.J. Koch, and H.A. Rockman Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure Proc. Natl. Acad. Sci. U. S. A. 98 10 2001 5809 5814
57. K. Freeman, I. Lerman, E.G. Kranias, T. Bohlmeyer, M.R. Bristow, R.J. Lefkowitz, G. Iaccarino, W.J. Koch, and L.A. Leinwand Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy J. Clin. Invest. 107 8 2001 967 974
58. H.A. Rockman, D.J. Choi, S.A. Akhter, M. Jaber, B. Giros, R.J. Lefkowitz, M.G. Caron, and W.J. Koch Control of myocardial contractile function by the level of beta-adrenergic receptor kinase 1 in gene-targeted mice J. Biol. Chem. 273 29 1998 18180 18184
59. 2+ handling phenotype resistant to adverse alterations and remodeling after myocardial infarction Circulation 125 17 2012 2108 2118 10.1161/circulationaha.111.044255
60. M. Volkers, C. Weidenhammer, N. Herzog, G. Qiu, K. Spaich, F. von Wegner, K. Peppel, O.J. Muller, S. Schinkel, J.E. Rabinowitz, H.J. Hippe, H. Brinks, H.A. Katus, W.J. Koch, A.D. Eckhart, O. Friedrich, and P. Most The inotropic peptide betaARKct improves betaAR responsiveness in normal and failing cardiomyocytes through G(betagamma)-mediated L-type calcium current disinhibition Circ. Res. 108 1 2011 27 39 10.1161/CIRCRESAHA.110.225201
61. H. Brinks, M. Boucher, E. Gao, J.K. Chuprun, S. Pesant, P.W. Raake, Z.M. Huang, X. Wang, G. Qiu, A. Gumpert, D.M. Harris, A.D. Eckhart, P. Most, and W.J. Koch Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms Circ. Res. 107 9 2010 1140 1149 10.1161/CIRCRESAHA.110.221010
62. S. Liu, R.T. Premont, C.D. Kontos, S. Zhu, and D.C. Rockey A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension Nat. Med. 11 9 2005 952 958
63. K. Kawasaki, R.S. Smith Jr., C.M. Hsieh, J. Sun, J. Chao, and J.K. Liao Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis Mol. Cell. Biol. 23 16 2003 5726 5737
64. E.J. Whalen, M.W. Foster, A. Matsumoto, K. Ozawa, J.D. Violin, L.G. Que, C.D. Nelson, M. Benhar, J.R. Keys, H.A. Rockman, W.J. Koch, Y. Daaka, R.J. Lefkowitz, and J.S. Stamler Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2 Cell 129 3 2007 511 522
65. P. Pagliaro, and C. Penna Redox signalling and cardioprotection: translatability and mechanism Br. J. Pharmacol. 172 8 2015 1974 1995 10.1111/bph.12975
66. Z.M. Huang, E. Gao, F.V. Fonseca, H. Hayashi, X. Shang, N.E. Hoffman, J.K. Chuprun, X. Tian, D.G. Tilley, M. Madesh, D.J. Lefer, J.S. Stamler, and W.J. Koch Convergence of G protein-coupled receptor and S-nitrosylation signaling determines the outcome to cardiac ischemic injury Sci. Signal. 6 299 2013 ra95 10.1126/scisignal.2004225
67. Q. Fan, M. Chen, L. Zuo, X. Shang, M.Z. Huang, M. Ciccarelli, P. Raake, H. Brinks, K.J. Chuprun, G.W. Dorn 2nd, W.J. Koch, and E. Gao Myocardial ablation of G protein-coupled receptor kinase 2 (GRK2) decreases ischemia/reperfusion injury through an anti-intrinsic apoptotic pathway PLoS One 8 6 2013 e66234 (Print 2013)
68. M. Chen, P.Y. Sato, J.K. Chuprun, R.J. Peroutka, N.J. Otis, J. Ibetti, S. Pan, S.S. Sheu, E. Gao, and W.J. Koch Prodeath signaling of G protein-coupled receptor kinase 2 in cardiac myocytes after ischemic stress occurs via extracellular signal-regulated kinase-dependent heat shock protein 90-mediated mitochondrial targeting Circ. Res. 112 8 2013 1121 1134 10.1161/CIRCRESAHA.112.300754
69. P.Y. Sato, J.K. Chuprun, J. Ibetti, A. Cannavo, K. Drosatos, J.W. Elrod, and W.J. Koch GRK2 compromises cardiomyocyte mitochondrial function by diminishing fatty acid-mediated oxygen consumption and increasing superoxide levels J. Mol. Cell. Cardiol. 89 Pt. B 2015 360 364 10.1016/j.yjmcc.2015.10.002
70. A. Fusco, G. Santulli, D. Sorriento, E. Cipolletta, C. Garbi, G.W. Dorn 2nd, B. Trimarco, A. Feliciello, and G. Iaccarino Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis Cell. Signal. 24 2 2012 468 475 10.1016/j.cellsig.2011.09.026
71. G.A. Porter Jr., J. Hom, D. Hoffman, R. Quintanilla, K. de Mesy Bentley, and S.S. Sheu Bioenergetics, mitochondria, and cardiac myocyte differentiation Prog. Pediatr. Cardiol. 31 2 2011 75 81
72. A. Cannavo, D. Liccardo, A. Eguchi, K.J. Elliott, C.J. Traynham, J. Ibetti, S. Eguchi, D. Leosco, N. Ferrara, G. Rengo, and W.J. Koch Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases Nat. Commun. 7 2016 10877 10.1038/ncomms10877
73. T. Theccanat, J.L. Philip, A.M. Razzaque, N. Ludmer, J. Li, X. Xu, and S.A. Akhter Regulation of cellular oxidative stress and apoptosis by G protein-coupled receptor kinase-2: the role of NADPH oxidase 4 Cell. Signal. 28 3 2016 190 203 10.1016/j.cellsig.2015.11.013
74. J. Abd Alla, M. Graemer, X. Fu, and U. Quitterer Inhibition of G-protein-coupled receptor kinase 2 prevents the dysfunctional cardiac substrate metabolism in fatty acid synthase transgenic mice J. Biol. Chem. 291 6 2016 2583 2600 10.1074/jbc.M115.702688
75. A. Lymperopoulos, G. Rengo, H. Funakoshi, A.D. Eckhart, and W.J. Koch Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure Nat. Med. 13 3 2007 315 323
76. A. Lymperopoulos, G. Rengo, C. Zincarelli, S. Soltys, and W.J. Koch Modulation of adrenal catecholamine secretion by in vivo gene transfer and manipulation of G protein-coupled receptor kinase-2 activity Mol. Ther. 16 2 2008 302 307 10.1038/sj.mt.6300371
77. A. Lymperopoulos, G. Rengo, E. Gao, S.N. Ebert, G.W. Dorn 2nd, and W.J. Koch Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction J. Biol. Chem. 285 21 2010 16378 16386 10.1074/jbc.M109.077859
78. G. Rengo, D. Leosco, C. Zincarelli, M. Marchese, G. Corbi, D. Liccardo, A. Filippelli, N. Ferrara, M.P. Lisanti, W.J. Koch, and A. Lymperopoulos Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure Am. J. Physiol. Heart Circ. Physiol. 298 6 2010 H2032 H2038 10.1152/ajpheart.00702.2009
79. G. Rengo, A. Lymperopoulos, C. Zincarelli, G. Femminella, D. Liccardo, G. Pagano, C. de Lucia, A. Cannavo, P. Gargiulo, N. Ferrara, P. Perrone Filardi, W. Koch, and D. Leosco Blockade of beta-adrenoceptors restores the GRK2-mediated adrenal alpha(2)-adrenoceptor-catecholamine production axis in heart failure Br. J. Pharmacol. 166 8 2012 2430 2440 10.1111/j.1476-5381.2012.01972.x
80. L.E. Vinge, P.W. Raake, and W.J. Koch Gene therapy in heart failure Circ. Res. 102 12 2008 1458 1470 10.1161/CIRCRESAHA.108.173195
81. A.S. Shah, D.C. White, S. Emani, A.P. Kypson, R.E. Lilly, K. Wilson, D.D. Glower, R.J. Lefkowitz, and W.J. Koch In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction Circulation 103 9 2001 1311 1316
82. H.T. Tevaearai, A.D. Eckhart, K.F. Shotwell, K. Wilson, and W.J. Koch Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor Circulation 104 17 2001 2069 2074
83. H.T. Tevaearai, G.B. Walton, J.R. Keys, W.J. Koch, and A.D. Eckhart Acute ischemic cardiac dysfunction is attenuated via gene transfer of a peptide inhibitor of the beta-adrenergic receptor kinase (betaARK1) J. Gene Med. 7 9 2005 1172 1177
84. J.D. Swain, A.S. Fargnoli, M.G. Katz, C.E. Tomasulo, M. Sumaroka, K.C. Richardville, W.J. Koch, J.E. Rabinowitz, and C.R. Bridges MCARD-mediated gene transfer of GRK2 inhibitor in ovine model of acute myocardial infarction J. Cardiovasc. Transl. Res. 6 2 2013 253 262 10.1007/s12265-012-9418-z
85. P.W. Raake, P. Schlegel, J. Ksienzyk, J. Reinkober, J. Barthelmes, S. Schinkel, S. Pleger, W. Mier, U. Haberkorn, W.J. Koch, H.A. Katus, P. Most, and O.J. Muller AAV6. betaARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model Eur. Heart J. 34 19 2013 1437 1447 10.1093/eurheartj/ehr447
86. D.M. Thal, K.T. Homan, J. Chen, E.K. Wu, P.M. Hinkle, Z.M. Huang, J.K. Chuprun, J. Song, E. Gao, J.Y. Cheung, L.A. Sklar, W.J. Koch, and J.J. Tesmer Paroxetine is a direct inhibitor of G protein-coupled receptor kinase 2 and increases myocardial contractility ACS Chem. Biol. 7 11 2012 1830 1839
87. K.T. Homan, E. Wu, M.W. Wilson, P. Singh, S.D. Larsen, and J.J. Tesmer Structural and functional analysis of G protein-coupled receptor kinase inhibition by paroxetine and a rationally designed analog Mol. Pharmacol. 85 2 2014 237 248
88. K.T. Homan, K.M. Larimore, J.M. Elkins, M. Szklarz, S. Knapp, and J.J. Tesmer Identification and structure-function analysis of subfamily selective G protein-coupled receptor kinase inhibitors ACS Chem. Biol. 10 1 2015 310 319
89. L.M. Casey, A.R. Pistner, S.L. Belmonte, D. Migdalovich, O. Stolpnik, F.E. Nwakanma, G. Vorobiof, O. Dunaevsky, A. Matavel, C.M. Lopes, A.V. Smrcka, and B.C. Blaxall Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure Circ. Res. 107 4 2010 532 539 10.1161/CIRCRESAHA.110.217075
90. F.A. Kamal, D.M. Mickelsen, K.M. Wegman, J.G. Travers, J. Moalem, S.R. Hammes, A.V. Smrcka, and B.C. Blaxall Simultaneous adrenal and cardiac G-protein-coupled receptor-gbetagamma inhibition halts heart failure progression J. Am. Coll. Cardiol. 63 23 2014 2549 2557
91. C.J. Traynham, J. Hullmann, and W.J. Koch Canonical and non-canonical actions of GRK5 in the heart J. Mol. Cell. Cardiol. 92 2016 196 202 10.1016/j.yjmcc.2016.01.027
92. H.A. Rockman, D.J. Choi, N.U. Rahman, S.A. Akhter, R.J. Lefkowitz, and W.J. Koch Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice Proc. Natl. Acad. Sci. U. S. A. 93 18 1996 9954 9959
93. J.S. Martini, P. Raake, L.E. Vinge, B.R. DeGeorge, Jr., J.K. Chuprun, D.M. Harris, E. Gao, A.D. Eckhart, J.A. Pitcher, and W.J. Koch Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes Proc. Natl. Acad. Sci. U. S. A. 105 34 2008 12457 12462 10.1073/pnas.0803153105
94. J.I. Gold, J.S. Martini, J. Hullmann, E. Gao, J.K. Chuprun, L. Lee, D.G. Tilley, J.E. Rabinowitz, J. Bossuyt, D.M. Bers, and W.J. Koch Nuclear translocation of cardiac G protein-coupled receptor kinase 5 downstream of select Gq-activating hypertrophic ligands is a calmodulin-dependent process PLoS One 8 3 2013 e57324 10.1371/journal.pone.0057324
95. Y. Zhang, S.J. Matkovich, X. Duan, J.I. Gold, W.J. Koch, and G.W. Dorn 2nd Nuclear effects of G-protein receptor kinase 5 on histone deacetylase 5-regulated gene transcription in heart failure Circ. Heart Fail. 4 5 2011 659 668 10.1161/CIRCHEARTFAILURE.111.962563
96. J.I. Gold, E. Gao, X. Shang, R.T. Premont, and W.J. Koch Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication Circ. Res. 111 8 2012 1048 1053
97. X.P. Yi, A.M. Gerdes, and F. Li Myocyte redistribution of GRK2 and GRK5 in hypertensive, heart-failure-prone rats Hypertension 39 6 2002 1058 1063
98. X.P. Yi, J. Zhou, J. Baker, X. Wang, A.M. Gerdes, and F. Li Myocardial expression and redistribution of GRKs in hypertensive hypertrophy and failure Anat. Rec. A: Discov. Mol. Cell. Evol. Biol. 282 1 2005 13 23
99. J.E. Hullmann, L.A. Grisanti, C.A. Makarewich, E. Gao, J.I. Gold, J.K. Chuprun, D.G. Tilley, S.R. Houser, and W.J. Koch GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity Circ. Res. 20 114 2014 304475
100. S. Patial, S. Shahi, Y. Saini, T. Lee, N. Packiriswamy, D.M. Appledorn, J.J. Lapres, A. Amalfitano, and N. Parameswaran G-protein coupled receptor kinase 5 mediates lipopolysaccharide-induced NFkappaB activation in primary macrophages and modulates inflammation in vivo in mice J. Cell. Physiol. 226 5 2011 1323 1333 10.1002/jcp.22460
101. N. Parameswaran, C.S. Pao, K.S. Leonhard, D.S. Kang, M. Kratz, S.C. Ley, and J.L. Benovic Arrestin-2 and G protein-coupled receptor kinase 5 interact with NFkappaB1 p105 and negatively regulate lipopolysaccharide-stimulated ERK1/2 activation in macrophages J. Biol. Chem. 281 45 2006 34159 34170
102. S. Valanne, H. Myllymaki, J. Kallio, M.R. Schmid, A. Kleino, A. Murumagi, L. Airaksinen, T. Kotipelto, M. Kaustio, J. Ulvila, S.S. Esfahani, Y. Engstrom, O. Silvennoinen, D. Hultmark, M. Parikka, and M. Ramet Genome-wide RNA interference in Drosophila cells identifies G protein-coupled receptor kinase 2 as a conserved regulator of NF-kappaB signaling J. Immunol. 184 11 2010 6188 6198 10.4049/jimmunol.1000261
103. K.N. Islam, J.W. Bae, E. Gao, and W.J. Koch Regulation of nuclear factor kappaB (NF-kappaB) in the nucleus of cardiomyocytes by G protein-coupled receptor kinase 5 (GRK5) J. Biol. Chem. 288 50 2013 35683 35689 10.1074/jbc.M113.529347
104. D. Sorriento, M. Ciccarelli, G. Santulli, A. Campanile, G.G. Altobelli, V. Cimini, G. Galasso, D. Astone, F. Piscione, L. Pastore, B. Trimarco, and G. Iaccarino The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha Proc. Natl. Acad. Sci. U. S. A. 105 46 2008 17818 17823 10.1073/pnas.0804446105
105. G.W. Dorn 2nd The fuzzy logic of physiological cardiac hypertrophy Hypertension 49 5 2007 962 970
106. J.H. van Berlo, M. Maillet, and J.D. Molkentin Signaling effectors underlying pathologic growth and remodeling of the heart J. Clin. Invest. 123 1 2013 37 45 10.1172/JCI62839
107. C.Y. Huang, A.L. Yang, Y.M. Lin, F.N. Wu, J.A. Lin, Y.S. Chan, F.J. Tsai, C.H. Tsai, C.H. Kuo, and S.D. Lee Anti-apoptotic and pro-survival effects of exercise training on hypertensive hearts J. Appl. Physiol. (1985) 112 5 2012 883 891 10.1152/japplphysiol.00605.2011
108. C.J. Traynham, A. Cannavo, Y. Zhou, A. Vouga, B.P. Woodall, J.E. Hullmann, J. Ibetti, J.I. Gold, J.K. Chuprun, E. Gao, and W.J. Koch Differential role of G protein-coupled receptor kinase 5 in physiological versus pathological cardiac hypertrophy Circ. Res. 29 115 2015 306961
109. B.J. Wilkins, Y.S. Dai, O.F. Bueno, S.A. Parsons, J. Xu, D.M. Plank, F. Jones, T.R. Kimball, and J.D. Molkentin Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy Circ. Res. 94 1 2004 110 118
110. S.B. Liggett, S. Cresci, R.J. Kelly, F.M. Syed, S.J. Matkovich, H.S. Hahn, A. Diwan, J.S. Martini, L. Sparks, R.R. Parekh, J.A. Spertus, W.J. Koch, S.L. Kardia, and G.W. Dorn 2nd A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure Nat. Med. 14 5 2008 510 517 10.1038/nm1750
111. M. Eijgelsheim, L.E. Visser, A.G. Uitterlinden, and B.H. Stricker Protective effect of a GRK5 polymorphism on heart failure and its interaction with beta-adrenergic receptor antagonists Pharmacogenomics 9 10 2008 1551 1555 10.2217/14622416.9.10.1551
112. K.T. Homan, E. Wu, A. Cannavo, W.J. Koch, and J.J. Tesmer Identification and characterization of amlexanox as a G protein-coupled receptor kinase 5 inhibitor Molecules 19 10 2014 16937 16949
113. S.M. Reilly, S.H. Chiang, S.J. Decker, L. Chang, M. Uhm, M.J. Larsen, J.R. Rubin, J. Mowers, N.M. White, I. Hochberg, M. Downes, R.T. Yu, C. Liddle, R.M. Evans, D. Oh, P. Li, J.M. Olefsky, and A.R. Saltiel An inhibitor of the protein kinases TBK1 and IKK-varepsilon improves obesity-related metabolic dysfunctions in mice Nat. Med. 19 3 2013 313 321
114. K.T. Homan, H.V. Waldschmidt, A. Glukhova, A. Cannavo, J. Song, J.Y. Cheung, W.J. Koch, S.D. Larsen, and J.J. Tesmer Crystal structure of G protein-coupled receptor kinase 5 in complex with a rationally designed inhibitor J. Biol. Chem. 290 34 2015 20649 20659
115. F. Baameur, R.A. Hammitt, J. Friedman, J.S. McMurray, and R.B. Clark Biochemical and cellular specificity of peptide inhibitors of G protein-coupled receptor kinases Int. J. Pept. Res. Ther. 20 1 2013 1 12
116. K. Rajagopal, E.J. Whalen, J.D. Violin, J.A. Stiber, P.B. Rosenberg, R.T. Premont, T.M. Coffman, H.A. Rockman, and R.J. Lefkowitz Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes Proc. Natl. Acad. Sci. U. S. A. 103 44 2006 16284 16289
117. K.N. Nobles, K. Xiao, S. Ahn, A.K. Shukla, C.M. Lam, S. Rajagopal, R.T. Strachan, T.Y. Huang, E.A. Bressler, M.R. Hara, S.K. Shenoy, S.P. Gygi, and R.J. Lefkowitz Distinct phosphorylation sites on the beta(2)-adrenergic receptor establish a barcode that encodes differential functions of beta-arrestin Sci. Signal. 4 185 2011 ra51
118. K. Rakesh, B. Yoo, I.M. Kim, N. Salazar, K.S. Kim, and H.A. Rockman Beta-arrestin-biased agonism of the angiotensin receptor induced by mechanical stress Sci. Signal. 3 125 2010 ra46
119. T. Noma, A. Lemaire, S.V. Naga Prasad, L. Barki-Harrington, D.G. Tilley, J. Chen, P. Le Corvoisier, J.D. Violin, H. Wei, R.J. Lefkowitz, and H.A. Rockman Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection J. Clin. Invest. 117 9 2007 2445 2458
120. G. Condorelli, M.V. Latronico, and G.W. Dorn 2nd microRNAs in heart disease: putative novel therapeutic targets? Eur. Heart J. 31 6 2010 649 658 10.1093/eurheartj/ehp573
121. S.J. Matkovich, W. Wang, Y. Tu, W.H. Eschenbacher, L.E. Dorn, G. Condorelli, A. Diwan, J.M. Nerbonne, and G.W. Dorn 2nd MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts Circ. Res. 106 1 2010 166 175 10.1161/CIRCRESAHA.109.202176
122. E. van Rooij, L.B. Sutherland, N. Liu, A.H. Williams, J. McAnally, R.D. Gerard, J.A. Richardson, and E.N. Olson A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure Proc. Natl. Acad. Sci. U. S. A. 103 48 2006 18255 18260
123. C. Sucharov, M.R. Bristow, and J.D. Port miRNA expression in the failing human heart: functional correlates J. Mol. Cell. Cardiol. 45 2 2008 185 192 10.1016/j.yjmcc.2008.04.014
124. A. Care, D. Catalucci, F. Felicetti, D. Bonci, A. Addario, P. Gallo, M.L. Bang, P. Segnalini, Y. Gu, N.D. Dalton, L. Elia, M.V. Latronico, M. Hoydal, C. Autore, M.A. Russo, G.W. Dorn 2nd, O. Ellingsen, P. Ruiz-Lozano, K.L. Peterson, C.M. Croce, C. Peschle, and G. Condorelli MicroRNA-133 controls cardiac hypertrophy Nat. Med. 13 5 2007 613 618 (Epub April 29, 2007)
125. A. Castaldi, T. Zaglia, V. Di Mauro, P. Carullo, G. Viggiani, G. Borile, B. Di Stefano, G.G. Schiattarella, M.G. Gualazzi, L. Elia, G.G. Stirparo, M.L. Colorito, G. Pironti, P. Kunderfranco, G. Esposito, M.L. Bang, M. Mongillo, G. Condorelli, and D. Catalucci MicroRNA-133 modulates the beta1-adrenergic receptor transduction cascade Circ. Res. 115 2 2014 273 283 10.1161/CIRCRESAHA.115.303252
126. J. Tamargo, and J. Lopez-Sendon Novel therapeutic targets for the treatment of heart failure Nat. Rev. Drug Discov. 10 7 2011 536 555 10.1038/nrd3431
127. M. Hu, C. Wang, W. Li, W. Lu, Z. Bai, D. Qin, Q. Yan, J. Zhu, B.J. Krueger, R. Renne, S.J. Gao, and C. Lu A KSHV microRNA directly targets G protein-coupled receptor kinase 2 to promote the migration and invasion of endothelial cells by inducing CXCR2 and activating AKT signaling PLoS Pathog. 11 9 2015 e1005171 10.1371/journal.ppat.1005171
128. N. Dzimiri, P. Muiya, E. Andres, and Z. Al-Halees Differential functional expression of human myocardial G protein receptor kinases in left ventricular cardiac diseases Eur. J. Pharmacol. 489 3 2004 167 177
129. J. Aguero, L. Almenar, F. Monto, E. Oliver, I. Sanchez-Lazaro, D. Vicente, L. Martinez-Dolz, P. D'Ocon, J. Rueda, and A. Salvador Myocardial G protein receptor-coupled kinase expression correlates with functional parameters and clinical severity in advanced heart failure J. Card. Fail. 18 1 2012 53 61 10.1016/j.cardfail.2011.10.008
130. N. Dzimiri, C. Basco, A. Moorji, B. Afrane, and Z. Al-Halees Characterization of lymphocyte beta 2-adrenoceptor signalling in patients with left ventricular volume overload disease Clin. Exp. Pharmacol. Physiol. 29 3 2002 181 188
131. F. Monto, E. Oliver, D. Vicente, J. Rueda, J. Aguero, L. Almenar, M.D. Ivorra, D. Barettino, and P. D'Ocon Different expression of adrenoceptors and GRKs in the human myocardium depends on heart failure etiology and correlates to clinical variables Am. J. Physiol. Heart Circ. Physiol. 303 3 2012 H368 H376 10.1152/ajpheart.01061.2011